Quad by MEDVi Review 2026: The 4-in-1 ED Treatment, Explained
The Fast Facts
- QUAD by MEDVi is a compounded men’s erectile-dysfunction (ED) treatment offered through MEDVi’s telehealth platform — it is not a weight-loss product.
- It combines four ingredients in one formula: sildenafil, tadalafil, vardenafil, and apomorphine, each of which has established FDA-approved uses individually.
- Because it is compounded, the finished combination is not FDA-approved, and it requires a prescription after evaluation by a licensed clinician.
Erectile dysfunction is common and treatable, and telehealth has made it easier to get care discreetly. A growing trend is the compounded combination product — blending several ED ingredients into a single formula. These can be convenient, but they also raise important questions about FDA status and safety.
In this Quad by MEDVi review, we explain what the product actually is, how the telehealth process works, the safety considerations that come with ED medication, and who it may suit — without giving medical advice.
A quick look at our picks
- The product: MEDVi QUAD 4-in-1 Formula
- PDE5 component: Sildenafil, Tadalafil, Vardenafil
- Additional pathway: Apomorphine
- The service: MEDVi Telehealth Consultation
What is QUAD by MEDVi?
QUAD is a compounded ED treatment prepared by a licensed compounding pharmacy on a physician’s prescription. It brings together four active ingredients in one formula: sildenafil (the active ingredient in Viagra), tadalafil (Cialis), vardenafil (Levitra), and apomorphine. The first three are PDE5 inhibitors; apomorphine works through a different, dopamine-related pathway.
It is offered through MEDVi, the same telehealth company known for GLP-1 weight-loss programs, but QUAD is a separate men’s-health product. Notably, the FDA warning letter MEDVi received in 2026 concerned its GLP-1 marketing and did not reference the QUAD line.
What is in QUAD and how it is offered
The items below describe a prescription product and its components. They require evaluation and approval by a licensed clinician and are not suitable for everyone.
MEDVi QUAD 4-in-1 Formula
- Type: compounded ED combination
- Contains: sildenafil, tadalafil, vardenafil, apomorphine
- Prescription: required after clinician review
- Note: compounded, not FDA-approved
Our review
QUAD’s pitch is convenience: four ED ingredients combined into a single compounded formula, intended to draw on more than one mechanism at once. For some men, a combination approach may be appealing.
The trade-off is that the finished product is compounded rather than FDA-approved, so its formulation and quality are not reviewed by the FDA the way a single approved drug is. A clinician should confirm it is appropriate and safe for you.
Product details
- Clinician-reviewed: required
- Compounded: yes
- Combination product: yes
- Adults only: yes
The PDE5 inhibitors (sildenafil, tadalafil, vardenafil)
- Class: PDE5 inhibitors
- Individually: FDA-approved for ED
- Familiar brands: Viagra, Cialis, Levitra
- Caution: must not be taken with nitrates
Our review
Sildenafil, tadalafil, and vardenafil are the best-known ED medications, each FDA-approved on its own. They improve blood flow and differ mainly in onset and duration — tadalafil, for example, lasts notably longer than sildenafil.
Combining multiple PDE5 inhibitors is not how these are typically prescribed individually, which is exactly why clinician oversight and an honest safety conversation matter here.
Product details
- FDA-approved individually: yes
- Different durations: yes
- Nitrate interaction: dangerous
- Clinician-reviewed: required
Apomorphine
- Class: dopamine agonist
- Role: acts on a different pathway than PDE5 drugs
- Use: studied for ED
- Caution: can cause nausea and low blood pressure
Our review
Apomorphine works centrally, through dopamine signaling, rather than on blood flow like the PDE5 inhibitors. Including it is meant to add a complementary mechanism.
It has its own side-effect profile, including nausea and blood-pressure effects, which is another reason a clinician needs to weigh whether this combination is right for an individual.
Product details
- Non-PDE5 pathway: yes
- Side effects: nausea, BP changes
- Clinician-reviewed: required
- Adults only: yes
MEDVi Telehealth Consultation
- Process: online evaluation
- Outcome: prescription if appropriate
- Delivery: discreet shipping
- Model: cash-pay
Our review
Access runs through MEDVi’s telehealth model: you complete an online evaluation, a licensed provider reviews it, and if appropriate, the prescription is filled and shipped discreetly.
As with the rest of MEDVi, it is cash-pay, and approval depends on your health history. Be thorough and honest in the intake, especially about heart conditions and medications.
Product details
- Online evaluation: yes
- Discreet shipping: yes
- Cash-pay: yes
- Approval not guaranteed: correct
Pros and cons at a glance
Pros
- combines four ED ingredients in one convenient compounded formula
- draws on more than one mechanism of action
- discreet, convenient telehealth access
- the individual ingredients are well studied and individually FDA-approved
- the 2026 FDA warning letter to MEDVi did not involve the QUAD line
Cons
- the finished combination is compounded and not FDA-approved
- combining multiple PDE5 inhibitors is not standard individual prescribing
- serious interaction risk with nitrates and caution with heart conditions
- apomorphine adds nausea and blood-pressure considerations
- cash-pay only, and not suitable for everyone
How the QUAD telehealth process works
You complete an online medical evaluation, a licensed clinician reviews it, and if QUAD is deemed appropriate, a prescription is issued and the compounded product is shipped discreetly. The convenience is real, but the intake is where safety is established, so accuracy about your heart health and current medications is essential.
Approval is not guaranteed, and a responsible provider may decline if the combination is not safe for you.
Safety and side effects you must know
ED medications carry serious safety considerations. PDE5 inhibitors must never be combined with nitrate medications (used for chest pain), because the combination can cause a dangerous drop in blood pressure. They also require caution in men with certain heart conditions or who take alpha-blockers. Possible side effects include headache, flushing, indigestion, and, rarely, a prolonged erection (priapism) that is a medical emergency if it lasts more than four hours.
Apomorphine adds the possibility of nausea and blood-pressure effects. Because QUAD stacks several of these, an open conversation with a clinician about your full medical history is not optional — it is the point.
The compounding question
QUAD is a compounded product, meaning a pharmacy combines the ingredients on a prescription. Compounded medications are not FDA-approved as finished products, so the specific combination has not been reviewed for safety and efficacy the way an approved single drug has. The individual ingredients are well known, but the blend is not an FDA-approved formulation. This is a key point to discuss with a provider.
Who QUAD is for
QUAD may appeal to adult men who have been evaluated by a clinician, want a convenient combination approach, and understand and accept the compounded nature of the product. It is not appropriate for anyone taking nitrates, men with certain cardiovascular conditions, or those who would be better served by a single, FDA-approved ED medication. When in doubt, a standard approved option under medical supervision is the more conservative route.
Understanding QUAD’s ingredients
| Ingredient | Class | Individually FDA-approved | Key caution |
|---|---|---|---|
| Sildenafil | PDE5 inhibitor | Yes | No nitrates |
| Tadalafil | PDE5 inhibitor | Yes | Long duration; no nitrates |
| Vardenafil | PDE5 inhibitor | Yes | No nitrates |
| Apomorphine | dopamine agonist | Yes (other uses) | Nausea, low blood pressure |
Frequently asked questions about MEDVi QUAD
Is QUAD by MEDVi a weight-loss product?
No. QUAD is a men’s erectile-dysfunction treatment. MEDVi’s GLP-1 weight-loss programs are a separate product line.
What is in QUAD?
A compounded combination of sildenafil, tadalafil, vardenafil, and apomorphine, prepared on a prescription by a compounding pharmacy.
Is QUAD FDA-approved?
No. It is a compounded product, so the finished combination is not FDA-approved, even though the individual ingredients are approved on their own.
Did the FDA warning letter involve QUAD?
No. The 2026 FDA warning letter to MEDVi concerned its GLP-1 weight-loss marketing and did not reference the QUAD line.
Who should not use ED medications like this?
Anyone taking nitrates, and many men with certain heart conditions, should avoid them. Always be evaluated by a licensed clinician first.
The takeaway
QUAD by MEDVi is a compounded, four-in-one erectile-dysfunction treatment delivered through telehealth — convenient and discreet, drawing on several mechanisms at once. The important context is that it is compounded and therefore not FDA-approved as a finished product, that stacking multiple ED ingredients is not standard individual prescribing, and that ED medications carry serious interactions, especially with nitrates. For adult men exploring ED treatment, QUAD is one option, but it is exactly the kind of product where a candid evaluation by a licensed clinician — and a fair look at standard FDA-approved alternatives — should come first.
Disclaimer
This article is for informational purposes only and is not medical advice. Erectile-dysfunction medications are prescription drugs with serious interactions and contraindications, including a dangerous interaction with nitrates; compounded combinations are not FDA-approved as finished products. Nothing here is a recommendation to start any treatment. Always consult a licensed healthcare provider about your individual situation. Details may change; verify on the provider’s official site. This article may contain affiliate links, and all brand names belong to their respective owners.
